New York, United States, March 15, 2024 (GLOBE NEWSWIRE) -- The Global Self Injection Device Market Size is to Grow from USD 6.5 Billion in 2023 to USD 10.7 Billion ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する